IRD
Opus Genetics
IRD
IRD
49 hedge funds and large institutions have $16M invested in Opus Genetics in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 41 → 49 (+8)
0.93% more ownership
Funds ownership: 16.61% → 17.55% (+0.93%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
49
Holding in Top 10
1
Calls
$1.42M
Puts
$36K
Top Buyers
| 1 | +$214K | |
| 2 | +$174K | |
| 3 | +$170K | |
| 4 |
Squarepoint
New York
|
+$151K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
+$144K |
Top Sellers
| 1 | -$392K | |
| 2 | -$119K | |
| 3 | -$73.6K | |
| 4 |
CC
Cornerstone Capital
Palo Alto,
California
|
-$61.3K |
| 5 |
Bank of New York Mellon
New York
|
-$61.3K |